Published in Dig Dis Sci on January 01, 2006
Persistent immune activation in chronic HIV infection: do any interventions work? AIDS (2013) 1.24
The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial. PLoS One (2014) 0.92
Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques. PLoS Pathog (2016) 0.81
Pathological mimics of chronic inflammatory bowel disease. J Clin Pathol (1991) 2.73
Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr (2002) 2.08
The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc (2000) 1.72
Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials (2001) 1.71
Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis (2004) 1.67
Diarrhea and reduced levels of antiretroviral drugs: improvement with glutamine or alanyl-glutamine in a randomized controlled trial in northeast Brazil. Clin Infect Dis (2004) 1.65
Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy. Dig Dis Sci (2003) 1.48
Histological discrimination of idiopathic inflammatory bowel disease from other types of colitis. J Clin Pathol (1995) 1.43
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study. Arch Intern Med (1999) 1.28
Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr (2002) 1.28
Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol (2000) 1.28
What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens. J Clin Pathol (1988) 1.23
Perspectives on gastrointestinal infections in AIDS. Gastroenterol Clin North Am (1988) 1.18
Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer (2002) 1.16
Gastrointestinal manifestations of human immunodeficiency virus infection. Adv Intern Med (1995) 1.16
The histopathology of 103 consecutive colonoscopy biopsies from 82 symptomatic patients with acquired immunodeficiency syndrome: original and look-back diagnoses. Arch Pathol Lab Med (2001) 1.08
Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea. Am J Gastroenterol (2001) 1.02
Drug-induced diarrhoea. Drug Saf (2000) 0.99
Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review. Dig Dis Sci (2002) 0.98
Diarrhea and quality of life in ambulatory HIV-infected patients. Dig Dis Sci (1996) 0.95
Gastrointestinal side effects of drugs. Expert Opin Drug Saf (2003) 0.94
Quality of life and health service use among HIV-infected patients with chronic diarrhea. J Acquir Immune Defic Syndr (1993) 0.93
Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects. Dig Liver Dis (2001) 0.84
Human immunodeficiency virus infection, the acquired immunodeficiency syndrome, and inflammatory bowel disease. J Clin Gastroenterol (1996) 0.82
Coadministration of indinavir and nelfinavir in human immunodeficiency virus type 1-infected adults: safety, pharmacokinetics, and antiretroviral activity. Antimicrob Agents Chemother (2002) 0.81
Non-steroidal anti-inflammatory drug-induced colitis. Int J Colorectal Dis (1996) 0.81
Chronic colitis associated with human immunodeficiency virus infection. Med J Aust (1992) 0.81
The role of mucosal biopsy in the diagnosis of chronic diarrhea: value of multiple biopsies when colonoscopic finding is normal or nonspecific. Korean J Intern Med (1997) 0.81
Inflammatory bowel disease in individuals seropositive for the human immunodeficiency virus. Eur J Gastroenterol Hepatol (1996) 0.80
Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir. Pharmacotherapy (2004) 0.80
Evaluation of chronic diarrhea in patients with human immunodeficiency virus infection. Rev Gastroenterol Disord (2002) 0.80
Investigation of diarrhea in AIDS. Can J Gastroenterol (2000) 0.79
Concomitant active Crohn's disease and the acquired immunodeficiency syndrome. Scand J Gastroenterol (1996) 0.78
L-glutamine supplementation improves nelfinavir-associated diarrhea in HIV-infected individuals. HIV Clin Trials (2003) 0.78
Impact of protease inhibitors on the outcome of human immunodeficiency virus-infected patients with chronic diarrhea. Am J Gastroenterol (1999) 0.77
[Biopsies of the endoscopically normal rectum and colon: a necessity. Incidence of collagen colitis and microscopic colitis]. Gastroenterol Clin Biol (1989) 0.77
[Evolution and treatment response in microscopic colitis]. Gastroenterol Hepatol (2001) 0.76
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks. J Acquir Immune Defic Syndr (2000) 0.76
Pathology of drug-associated gastrointestinal disease. Br J Clin Pharmacol (2003) 0.75
Organ-specific manifestations of HIV infection. I. Gastrointestinal diseases. AIDS (1993) 0.75
Managing and treating. AIDS-related diarrhea. Adv Nurse Pract (1998) 0.75
The efficacy of calcium carbonate in the treatment of protease inhibitor-induced persistent diarrhea in HIV-infected patients. HIV Clin Trials (2004) 0.75
[Drug-induced enterocolitis. Important differential diagnosis in the investigation of diarrhea and intestinal hemorrhage]. Lakartidningen (2000) 0.75
Collagenous colitis and lymphocytic colitis: clinical and endoscopic findings. Rev Esp Enferm Dig (2000) 0.75
Complications of HIV therapy. Hopkins HIV Rep (2000) 0.75
The use of calcium carbonate in nelfinavir-associated diarrhoea in HIV-1-infected patients. HIV Med (2003) 0.75
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
Opportunities to use drugs and stages of drug involvement outside the United States: Evidence from the Republic of Chile. Drug Alcohol Depend (2009) 1.13
Parental monitoring at age 11 and smoking initiation up to age 17 among Blacks and Whites: a prospective investigation. Nicotine Tob Res (2009) 0.96
Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis. Ann Hepatol (2008) 0.88
Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender. J Clin Gastroenterol (2006) 0.86
Student performance on smoking cessation counseling with standardized patients. Fam Med (2011) 0.84
Weight affect relapse rates in latinos with genotype 2/3 chronic hepatitis C (CHC) treated with peg IFN alfa-2a (Pegasys) 180 mcg/week and 800 mg daily of ribavirin for 24 weeks. J Med Virol (2008) 0.82
Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy. J Clin Virol (2006) 0.82
Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: a paired liver biopsy study. J Hepatol (2007) 0.79
Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C. P R Health Sci J (2004) 0.79
High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin. Dig Dis Sci (2005) 0.77
Behavioral problems and the occurrence of tobacco, cannabis, and coca paste smoking in Chile: evidence based on multivariate response models for school survey data. Drug Alcohol Depend (2009) 0.77
Incidence of Multiple Sclerosis in Puerto Rico, 2014: A Population-Based Study. Neuroepidemiology (2017) 0.75
Evolution of faculty affairs and faculty development offices in U.S. medical schools: a 10-year follow-up survey. Acad Med (2013) 0.75